Back to search

Article

Clinical Performance of the Alinity m HR HPV Assay in a Large Urban Cervical Cancer Screening Program in the United States

2024-02-13

Abstract excerpt

<h4>Background</h4> Certain high-risk human papillomavirus (HR HPV) genotypes may carry greater risk of progression to high-grade cervical cancer, and extended HR HPV genotyping may help refine risk assessment. <h4>Objectives</h4> To examine the performance of the Alinity m HR HPV assay in comparison to cobas 4800 HPV assay (cobas 4800) and the association between cytology results, age, and extended HR HPV genotyp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
32d78a6a-3f90-504f-8588-048f8bea4321
DOI
10.1101/2024.02.12.24302707
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical Performance of the Alinity m HR HPV Assay in a Large Urban Cervical Cancer Screening Program in the United StatesDOI 10.1101/2024.02.12.24302707
Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening setting.Semantic proximity
Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings.Semantic proximity
Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study.Semantic proximity
High-Risk Human Papillomavirus Detection via Cobas® 4800 and REBA HPV-ID® Assays.Semantic proximity
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytologySemantic proximity
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.Semantic proximity
Retrospective analysis of HPV infection: Cotesting and HPV genotyping in cervical cancer screening within a large academic health care system.Semantic proximity
Prevalence of co-infection between high-risk human papillomavirus and common sexually transmitted infections in cervical specimensSemantic proximity
HPV testing with 16/18 genotyping for risk stratification among women with normal cytology: a multicenter prospective cohort study from China.Semantic proximity
Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial.Semantic proximity
Clinical significance of extended high-risk human papillomavirus genotyping and viral load in cervical cancer and precancerous lesionsSemantic proximity
Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening.Semantic proximity
Select a neighboring publication to make it the new centre.